Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Acetaminophen × Gynecologic × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Thoracic 2 Lymphoid 2 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 66 pembrolizumab 54 Carboplatin 54 Bevacizumab 49 Cisplatin 34 Specimen Handling 29 Drug Therapy 22 Blood Specimen Collection 20 olaparib 19 Magnetic Resonance Spectroscopy 17 Biopsy 16 Cyclophosphamide 15 niraparib 12 fludarabine 12 Taxes 12 Letrozole 12 Gemcitabine 12 abemaciclib 10 Fulvestrant 10 liposomal doxorubicin 9 dostarlimab 9 Radiotherapy 9 Nivolumab 9 Injections 8 Docetaxel 8 Brachytherapy 8 toripalimab 7 mirvetuximab soravtansine 7 lenvatinib 7 camrelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824467 2026-03-13

TroFuse-022

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡